CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Abbott India Ltd.

NSE : ABBOTINDIAEQ BSE : 500488 ISIN CODE : INE358A01014Industry : Pharmaceuticals

News

  • Abbott India - Announcement under Regulation 30 (LODR)-Change in Management 22 Apr 2026 | 12:33 | Dion Global

    Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.more...

  • Abbott India - Board Meeting Outcome for Outcome Of Board Meeting 22 Apr 2026 | 12:30 | Dion Global

    Outcome of Board Meeting.more...

  • Abbott India has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 10 Apr 2026 | 17:41 | Dion Global

    As of March 2026 74.99% is owned by Foreign Promoters and 25.01% by Public. Institutional holds 9.20% (Insurance Companies 1.04%) and Non-Institution...more...

  • Abbott India - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 08 Apr 2026 | 16:09 | Dion Global

    Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the qu...more...

  • Abbott India - Announcement under Regulation 30 (LODR)-Press Release / Media Release 27 Feb 2026 | 15:41 | Dion Global

    Abbott partners with Novo Nordisk India to launch Extensior broadening access to Semaglutide (Ozempic) for advanced diabetes management.more...

  • Abbott India - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report 18 Feb 2026 | 15:10 | Dion Global

    Voting Results along with the Consolidated Scrutinizer s Report.more...

  • Abbott India Q3 net profit up 4.21% at Rs 375.96 cr 12 Feb 2026 | 13:50 | Dion Global

    The company reported standalone net profit of Rs 375.96 crore for the quarter ended December 31 2025 as compared to Rs 360.78 crore in the same perio...more...

  • Abbott India - Unaudited Financial Results Of The Company For The Quarter Ended December 31, 2025. 12 Feb 2026 | 13:33 | Dion Global

    Unaudited Financial Results of the Company for the quarter ended December 31 2025.more...

  • Abbott India - Board Meeting Outcome for Outcome Of Board Meeting. 12 Feb 2026 | 13:27 | Dion Global

    Outcome of Board Meeting.more...

  • Abbott India - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 04 Feb 2026 | 10:28 | Dion Global

    Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider...more...

  • Abbott India Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025 14 Jan 2026 | 15:31 | Dion Global

    As of December 2025 74.99% is owned by Foreign Promoters and 25.01% by Public. Institutional holds 9.19% (Insurance Companies 1.06%) and Non-Institut...more...

  • Abbott India Ltd. - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 14 Jan 2026 | 12:31 | Dion Global

    Postal Ballot Notice - Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirem...more...

  • Abbott India Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 08 Jan 2026 | 11:58 | Dion Global

    Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter end...more...

  • Abbott India Ltd. - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Dis 31 Dec 2025 | 12:29 | Dion Global

    Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.more...

  • Abbott India Ltd. - Announcement under Regulation 30 (LODR)-Change in Directorate 24 Dec 2025 | 19:49 | Dion Global

    Appointment of Mr. Vivek Mohan (DIN : 00075006) as Additional (Non-Executive) Director with effect from January 1 2026.more...

  • Abbott India Ltd. - Announcement under Regulation 30 (LODR)-Change in Management 25 Nov 2025 | 18:02 | Dion Global

    Change in Senior Management Personnel.more...

  • Abbott India Ltd. - Approval Of Central Government For Appointment Of Managing Director 24 Nov 2025 | 13:59 | Dion Global

    Approval of Central Government for appointment of Managing Directormore...

  • Abbott India Q2 net profit up 15.80% at Rs 415.27 cr 06 Nov 2025 | 14:51 | Dion Global

    The company reported standalone net profit of Rs 415.27 crore for the quarter ended September 30 2025 as compared to Rs 358.61 crore in the ...more...

  • Abbott India Ltd. - Unaudited Financial Results For The Quarter Ended September 30, 2025. 06 Nov 2025 | 13:33 | Dion Global

    Unaudited financial results for the quarter ended September 30 2025.more...

  • Abbott India Ltd. - Board Meeting Outcome for Outcome Of Board Meeting 06 Nov 2025 | 13:24 | Dion Global

    Outcome of Board Meeting.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex77816.441.21%
NSE Index24292.61.23%
B500DIVL503702.930.53%
BSE 1000 10715.790.97%
BSE 100LCTMC9109.941.05%
BSE Auto 58143.272.05%

Commodity

Gold148550-1.41%
Silver237523-2.59%
Copper1270211.43%
Crude Oil944547.28%
Lead203.3551.30%
Mentha Oil1118.74.81%
Nickel1824.3137.88%

Currency

USD/INR 94.30(0.23 %)
GBP/INR 126.95(0.00 %)
EUR/INR 110.14(0.00 %)
JPY/INR 0.59(0.11 %)
CAD/INR 68.93(0.36 %)
HKD/INR 12.03(0.15 %)